Evaluation of Postural Control in Premature Children

Marmara University

Status: Unknown

Conditions: Premature Birth

Treatments: Device: Neurocom balance master device

Study type: Observational

Funder types: Other

Identifiers

NCT04562909

09.2020.815

Details and patient eligibility

About

To date, it is largely unknown whether preterm children experience balance problems and whether they have normal postural control. Assuming that postural adaptation is affected after preterm delivery because it depends on attention and fine motor control, the postural control and motor development of children born preterm less than 32 weeks in the 5-7 age period will be affected compared to their healthy controls. Identifying these situations according to their healthy peers will improve the general health of premature births and enable better intervention methods to be designed.

Full description

Thanks to modern technical interventions and trained health personnel, the survival rate of premature babies has increased significantly in recent years. Neurodevelopmental abnormalities increase as birth weight and gestational week decrease and the presence of adverse biological conditions add up. Brain structures involved in fine motor control, such as the cerebellum, basal ganglia, corpus callosum, amygdala, and hippocampus, are smaller in babies born preterm, even without premature brain damage. Many of the problems associated with these in children are often difficult to detect at an early age, so numerous symptoms may not be detected until school age. In this sense, making periodic assessments of the progress in each child's motor development is essential to identifying deficiencies and thus facilitates referral to early intervention programs.

Enrollment: 72 estimated patients

Sex: All

Ages: 5 to 7 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Premature children born less than 32 weeks
• Age between 5-7 years
• Neurological development to be normal
• Giving an informed consent

Exclusion criteria

• Not giving an informed consent

Trial design

72 participants in 2 patient groups

Premature children

Description:

Premature children born before than 32 weeks were included.

Treatment:

Device: Neurocom balance master device

Healthy Control Group

Description:

Age matched healthy controls

Treatment:

Device: Neurocom balance master device